cyclopentane has been researched along with carfilzomib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ehrenschwender, M; El-Mesery, M; Leich, E; Rauert-Wunderlich, H; Rosenthal, T; Schlosser, A; Schreder, M; Siegmund, D; Stühmer, T; Wajant, H | 1 |
Huibregtse, JM; Matouschek, A; Tomita, T | 1 |
2 other study(ies) available for cyclopentane and carfilzomib
Article | Year |
---|---|
The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1
Topics: Adult; Aged; Apoptosis; Bortezomib; Cell Line, Tumor; Cell Survival; Cyclopentanes; Female; Humans; Male; Middle Aged; Multiple Myeloma; Necrosis; NF-kappa B; Oligopeptides; Pyrimidines; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Tumor Necrosis Factor-alpha; Ubiquitin-Activating Enzymes | 2019 |
A masked initiation region in retinoblastoma protein regulates its proteasomal degradation.
Topics: Acrylates; Calpain; Cell Cycle; Cell Transformation, Neoplastic; Cyclopentanes; E2F Transcription Factors; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Human papillomavirus 16; Humans; NEDD8 Protein; Oligopeptides; Papillomavirus E7 Proteins; Proteasome Endopeptidase Complex; Protein Stability; Pyrimidines; Recombinant Proteins; Retinoblastoma Binding Proteins; Ubiquitin-Protein Ligases; Ubiquitination; Uterine Cervical Neoplasms | 2020 |